Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GRAMICIDIN\NEOMYCIN\POLYMYXIN B: 562 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
562
Total FAERS Reports
10 (1.8%)
Deaths Reported
205
Hospitalizations
562
As Primary/Secondary Suspect
4
Life-Threatening
4
Disabilities

Active Ingredient: GRAMICIDIN\NEOMYCIN SULFATE\POLYMYXIN B SULFATE ·

First Report: 20020621 · Latest Report: 20240401

What Are the Most Common GRAMICIDIN\NEOMYCIN\POLYMYXIN B Side Effects?

#1 Most Reported
Drug ineffective
512 reports (91.1%)
#2 Most Reported
Macular degeneration
491 reports (87.4%)
#3 Most Reported
Pyrexia
182 reports (32.4%)

All GRAMICIDIN\NEOMYCIN\POLYMYXIN B Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Drug ineffective 512 91.1% 0 185
Macular degeneration 491 87.4% 0 187
Pyrexia 182 32.4% 8 171
Malaise 181 32.2% 7 170
Pain 181 32.2% 1 171
Therapeutic product effect incomplete 176 31.3% 0 172
Weight decreased 176 31.3% 1 172
Off label use 175 31.1% 2 170
Chronic sinusitis 174 31.0% 0 170
Nausea 174 31.0% 0 170
Paraesthesia oral 174 31.0% 0 170
Infusion related reaction 170 30.3% 9 159
Dyspepsia 158 28.1% 1 154
Procedural pain 156 27.8% 0 152
Headache 125 22.2% 2 124
Colitis ulcerative 124 22.1% 3 123
Constipation 124 22.1% 0 123
Erythema 124 22.1% 0 123
Female genital tract fistula 124 22.1% 0 123
Frequent bowel movements 124 22.1% 1 123

Who Reports GRAMICIDIN\NEOMYCIN\POLYMYXIN B Side Effects? Age & Gender Data

Gender: 94.0% female, 6.0% male. Average age: 67.1 years. Most reports from: CA. View detailed demographics →

Is GRAMICIDIN\NEOMYCIN\POLYMYXIN B Getting Safer? Reports by Year

YearReportsDeathsHosp.
2002 1 0 0
2014 1 0 0
2015 2 0 1
2016 1 0 0
2017 1 0 0
2018 10 0 10
2019 1 0 0
2023 1 0 0
2024 1 0 1

View full timeline →

What Is GRAMICIDIN\NEOMYCIN\POLYMYXIN B Used For?

IndicationReports
Product used for unknown indication 469
Ulcerative keratitis 11
Endophthalmitis 8
Keratitis bacterial 8
Staphylococcal infection 8
Klebsiella infection 7
Serratia infection 6
Skin laceration 6
Pseudomonas infection 5

GRAMICIDIN\NEOMYCIN\POLYMYXIN B vs Alternatives: Which Is Safer?

GRAMICIDIN\NEOMYCIN\POLYMYXIN B vs GRAMICIDIN\POLYMYXIN B GRAMICIDIN\NEOMYCIN\POLYMYXIN B vs GRANISETRON GRAMICIDIN\NEOMYCIN\POLYMYXIN B vs GRANULOCYTE COLONY-STIMULATING FACTOR NOS GRAMICIDIN\NEOMYCIN\POLYMYXIN B vs GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR GRAMICIDIN\NEOMYCIN\POLYMYXIN B vs GRAZOPREVIR GRAMICIDIN\NEOMYCIN\POLYMYXIN B vs GRISEOFULVIN GRAMICIDIN\NEOMYCIN\POLYMYXIN B vs GUAIFENESIN GRAMICIDIN\NEOMYCIN\POLYMYXIN B vs GUAIFENESIN\HYDROCODONE GRAMICIDIN\NEOMYCIN\POLYMYXIN B vs GUAIFENESIN\PSEUDOEPHEDRINE GRAMICIDIN\NEOMYCIN\POLYMYXIN B vs GUANFACINE

Official FDA Label for GRAMICIDIN\NEOMYCIN\POLYMYXIN B

Official prescribing information from the FDA-approved drug label.